Clinical trial · Interventional
Serological Screening of Gastric Cancer in Wuxi Region
NCT02663427CI-TRIAL-00020658unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine whether detection of pepsinogen Ⅰand Ⅱ combined with Helicobacter pylori antibody, so-called ABC method , is fit on gastric cancer screening in community of Wuxi City.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stomach Neoplasms | Gastric Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| serological examination and gastroscope | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- PG(-) and Hp(-) Group
- description
- PG negative （pepsinogen（PG）Ⅰ \> 70ng/ml or PGⅠ/PGⅡ \>7.0）and Hp (helicobacter pylori) negative. A questionnaire survey are accomplished in 40-70 years old candidates. Eligible subjects are detected PG I and II, Hp-IgG antibody through serological examination. Gastroscope also accomplished in all participants.
- interventionNames
- Device: serological examination and gastroscope
- type
- EXPERIMENTAL
- label
- PG(-) and Hp(+) Group
- description
- PG negative and Hp positive. A questionnaire survey are accomplished in 40-70 years old candidates. Eligible subjects are detected PG I and II, Hp-IgG antibody through serological examination. Gastroscope also accomplished in all participants.
- interventionNames
- Device: serological examination and gastroscope
- type
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: Age 40-70 years old, men and women are not limited, and there are one of the following: 1. Hp infected. 2. Previously suffering from chronic atrophic gastritis, gastric ulcer, gastric polyps, hypertrophic gastritis, pernicious anemia and other precancerous diseases of the stomach. 3. First degree relatives of patients with gastric cancer. 4. Other risk factors for gastric cancer. (high salt, salted diet, smoking, heavy drinking, etc.) Exclusion Criteria: 1. Severe heart, liver, kidney, dysfunction or mental disorders 2. History of gastric surgery (including surgery, minimally invasive EMR, ESD) 3. Use of PPI, acid preparation, stomach protecting agent in the first two weeks 4. The researchers considered inappropriate participants. 5. Informed consent cannot be attained
References
Publications (0)
Data not yet available
No reference posted for this study.